Apogee Therapeutics, Inc. Common Stock Net Asset Quality Index
Apogee Therapeutics, Inc. Common Stock net asset quality index. Apogee Therapeutics, Inc. Common Stock (APGE) has a Net Asset Quality Index of 89.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.34 Billion minus total liabilities of $141.21 Million yields net assets of $1.19 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Explore APGE debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Apogee Therapeutics, Inc. Common Stock (2022–2025)
Net asset quality index of Apogee Therapeutics, Inc. Common Stock from 2022 to 2025. This chart shows how Apogee Therapeutics, Inc. Common Stock's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 89.4%, representing net assets of $1.19 Billion against total assets of $1.34 Billion USD. See shareholders equity of Apogee Therapeutics, Inc. Common Stock for net asset value and shareholders' equity analysis.
Apogee Therapeutics, Inc. Common Stock Net Asset Quality Index by Year (2022–2025)
Apogee Therapeutics, Inc. Common Stock net asset quality index by year from 2022 to 2025. The table below presents the year-by-year Net Asset Quality Index for Apogee Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Apogee Therapeutics, Inc. Common Stock.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 96.5% | $903.88 Million | $937.13 Million | $33.25 Million | ▲ +1.4 pp |
| 2024 | 95.1% | $716.79 Million | $753.95 Million | $37.16 Million | ▲ +0.4 pp |
| 2023 | 94.6% | $379.91 Million | $401.40 Million | $21.49 Million | ▲ +1.2 pp |
| 2022 | 93.4% | $142.07 Million | $152.06 Million | $9.98 Million | — |